Evaluating the Neuroprotective Effects of a Test Compound Against Alpha-Synuclein Toxicity in Rat Embryonic Neurons

Start with a primary midbrain culture from rat embryos, containing dopaminergic neurons that overexpress mutated alpha-synuclein.

Replace the media in the treatment wells with fresh media containing the test compound, and that in the control wells with plain media. Then incubate.

In the control, alpha-synuclein forms toxic aggregates in dopaminergic neurons, causing neurite retraction and leading to neuronal death.

In the treatment, the test compound interacts with alpha-synuclein, prevents its aggregation, preserves neurite structure, and provides neuroprotection.

Fix and permeabilize the cells, then block non-specific binding sites.

Incubate with primary antibodies to label all neurons, with additional labeling for dopaminergic neurons.

Wash the cells and add fluorophore-tagged secondary antibodies specific to the primary antibodies.

Using an inverted fluorescence microscope, count the differentially-labeled dopaminergic neurons, then switch to a confocal microscope to measure neurite length.

A higher count of dopaminergic neurons with intact neurites in the treatment compared to the controls confirms the test compound’s neuroprotective potential.